Evidence map›Paper›PMID 31194046›Full record

ArticleMolecular genetics and metabolism reports2019

Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann - Pick type C and Sanfilippo diseases.

Evangelia Dimitriou, Evangelia Paschali, Maria Kanariou, Helen Michelakakis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular genetics and metabolism reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Evangelia DimitriouDepartment of Enzymology and Cellular Function, Institute of Child Health, Athens, Greece.
Evangelia PaschaliDepartment of Immunology and Histocompatibility Specialized Center & Referral Center for Primary Immunodeficiencies, Paediatric Immunology, 'Aghia Sophia' Children's Hospital, Athens, Greece.
Maria KanariouDepartment of Immunology and Histocompatibility Specialized Center & Referral Center for Primary Immunodeficiencies, Paediatric Immunology, 'Aghia Sophia' Children's Hospital, Athens, Greece.
Helen MichelakakisDepartment of Enzymology and Cellular Function, Institute of Child Health, Athens, Greece.
Children's Hospital Agia Sophia · GRInstitute of Child Health · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysosomal Storage Diseases (LSDs) are rare genetic diseases, the majority of which are caused by specific lysosomal enzyme deficiencies and all are characterized by malfunctioning lysosomes. Lysosomes are key regulators of many different cellular processes and are vital for the function of the immune system. Several studies have shown the coexistence of LSDs and immune abnormalities. In this study, we investigated the presence of autoantibodies in the plasma of patients with Gaucher disease (GD;

Indexed as

AGSA, Antiganglioside antibodiesAMA-M2, antimitochondrial antibodies to M2 antigenAutoimmunityGaucher diseaseGD, Gaucher diseaseImmunoglobulinsJo-1, Histidyl-tRNA synthetase antigenKu:Ku antigen(p70/p80)CENP A,B,C, Centromere proteins A,B,CLSDs, Lysosomal storage diseasesNiemann pick type C diseaseNPC, Niemann Pick type C diseasePM-Scl-70, Polymyositis - Scleroderma-70rib-P-Protein, Ribosomal P proteinRNP, ribonucleoproteinSanfilippo B syndromeScl-70, Scleroderma-70SFB, Sanfilippo B syndromeSm, Smith antigen (B,B′,D,E,F,G proteins)SS-A, Sjögren's antigen ASS-B, Sjögren's syndrome antigen B

Identifiers

PMID31194046
PMCPMC6554541
OpenAlexW2948817350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.